Assignment of Assignor's Interest

Recorded: 2025-04-23 Pages: 19

Assignors

SCHLEGEL, MARK K.

Executed: 2021-04-13

JANAS, MAJA

Executed: 2021-04-14

JADHAV, VASANT R.

Executed: 2020-09-09

FOSTER, DONALD

Executed: 2021-03-15

MANOHARAN, MUTHIAH

Executed: 2020-10-06

RAJEEV, KALLANTHOTTATHIL G.

Executed: 2020-06-05

JAYARAMAN, MUTHUSAMY

Executed: 2020-10-26

KEL'IN, ALEXANDER V.

Executed: 2021-04-30

MATSUDA, SHIGEO

Executed: 2021-04-14

CHARISSE, KLAUS

Executed: 2021-04-13

NAIR, JAYAPRAKASH K.

Executed: 2021-04-16

MAIER, MARTIN A.

Executed: 2020-10-20

SEHGAL, ALFICA

Executed: 2021-01-15

BROWN, CHRISTOPHER

Executed: 2021-04-28

THEILE, CHRISTOPHER

Executed: 2021-04-28

MILSTEIN, STUART

Executed: 2020-10-17

Assignee

ALNYLAM PHARMACEUTICALS, INC.

300 THIRD STREET, THIRD FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Property (1)

Modified Rna Agents with Reduced Off-Target Effect

Application: 19/025,271 →

Publication: US 2025/0205272

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.